EP2995315
Samsetningar og aðferðir til meðhöndlunar á krabbameini í blóði sem miða á Sirp-alfa-CD47 víxlverkunina
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.5.2010EP published:
27.12.2023EP application number:
15160169.7
EP translation filed:
26.2.2024Grant published:
15.3.2024EPO information:
European Patent Register
Max expiry date:
13.5.2030Expiry date:
13.5.2026Next due date:
31.5.2026
Title in English:
COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGIC CANCERS TARGETING THE SIRP ALPHA- CD47 INTERACTIONLanguage of the patent:
English
Timeline
Today
14.5.2010EP application
27.12.2023EP Publication
26.2.2024Translation submitted
15.3.2024Registration published
13.5.2026Expires
Owner
Name:
University Health NetworkAddress:
190 Elizabeth Street R. Fraser Elliott Building - Room 1S-417, Toronto, Ontario M5G 2C4, CA
Name:
The Hospital For Sick ChildrenAddress:
555 University Avenue, Toronto, Ontario M5G 1X8, CA
Inventor
Name:
Wang, C. Y. JeanAddress:
Toronto Ontario, M5N 1N6, CA
Name:
Dick, JohnAddress:
Toronto Ontario, M4E 2Z8, CA
Name:
Danska, JayneAddress:
Toronto Ontario, M5R 3C4, CA
Name:
Jin, LiqingAddress:
Toronto Ontario, M6P 4B2, CA
Name:
Theocharides, AlexandreAddress:
8002 Zürich, CH
Name:
Rajakumar, SujeethaAddress:
Toronto Ontario, M5B 2E8, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
178553 PDate:
15.5.2009Country:
US
Classification
Categories:
C12Q 1/6886
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 5.4.2024
Expires: 13.5.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 5.5.2025
Expires: 13.5.2026
Payer: Árnason Faktor ehf.